Sleep Apnea Devices Market Share and Size | Forecast to 2025

Sleep Apnea Devices Market to 2025 - Global Analysis and Forecasts by Diagnostic Devices (Polysomnography Devices, Respiratory Polygraphs, Actigraphy Systems, and Single-Channel Screening Devices); Therapeutic Devices (Facial Interfaces, Adaptive Servo-Ventilation Instruments (ASV), Positive Airway Pressure (PAP) Devices, Oxygen Concentrators, Airway Clearance Systems, Oral Appliances and Accessories); and End User (Home Healthcare and Sleep Laboratories & Hospitals)

Publication Month : Apr 2018

  • Report Code : TIPHE100000846
  • Category : Medical Device
  • Status : Published
  • No. of Pages : 171
Inquire Before Buy

PRICING

$4550

$2730

[Research Report] The sleep apnea devices market was valued at US$ 4,033.0 million in 2016 and it is projected to reach US$ 8,305.3 million in 2025; it is expected to grow at a CAGR of 7.9% from 2016 to 2025.

Market Insights and Analyst View:

Sleep apnea is a medical condition wherein breathing repeatedly stops and starts during sleep. Sleep apnea has three types: central sleep apnea, obstructive sleep apnea (OSA), and complex sleep apnea syndrome. Factors that narrow the airway, such as large tonsils, obesity, nasal congestion, constant smoking and drinking, family history, and changes in hormone levels, can increase the patient's risk for sleep apnea. The symptoms of sleep apnea are variations in breathing, loud snoring, waking in between sleep, lack of attention, excess daytime sleep, irritability, and lack of sleep during the night.

The increasing prevalence of respiratory diseases, sedentary lifestyle, increasing aging population (over 60 years), and growing prevalence of chronic disorders is likely to contribute to the rise in the prevalence of sleep apnea. Also, increasing life expectancy across the globe is likely to increase the prevalence of sleep disorders. The study ‘Global Prevalence of Obstructive Sleep Apnea in the Elderly and Related Factors: A Systematic Review and Meta-Analysis Study,’ published in June 2023, aimed to combine data and statistics on the worldwide prevalence of OSA in the elderly population. It combined data from 39 studies with a total sample size of 33,353 people were included. The pooled prevalence of OSA in the elderly population was 35.9% (95% confidence interval: 28.7%-43.8%; I2 = 98.81%). Thus, the abovementioned factors are likely to propel the global sleep apnea devices market size.

Customize Research To Suit Your Requirement

We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.

Sleep Apnea Devices Market: Strategic Insights

sleep-apnea-devices-market
Market Size Value inUS$ 4,033.0 Million in 2016
Market Size Value byUS$ 8,305.3 Million by 2025
Growth rateCAGR of 7.9% from 2017 to 2025
Forecast Period2016-2025
Base Year2017
Analyst Image

Akshay

Have a question?

Akshay will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.

Analyst Image  Speak to Analyst

Growth Drivers and Challenges:

Obstructive sleep apnea (OSA) is a normal and very common disorder categorized by the upper airway's repetitive, complete, or partial closure. In contrast, sleep is helpful in the fragmentation of sleep and oxygen desaturation. The disorder causes significant morbidity, especially in terms of impairment of daytime functioning and the impact this has on quality of life. The recent indication from the controlled trials is proof that oral appliance therapy is very effective in controlling OSA in up to 50.0% of patients, including some patients with more severe forms of OSA. This is associated with a significant improvement in symptoms, including snoring and daytime sleepiness. This evidence is strong for short-term and emerging long-term treatment of OSA with oral appliances. Various companies have developed their products for treating sleep apnea and related accessories. For instance, SomnoDent devices developed by SomnoMed Limited have increased in the previous year, 2016, from 68% to 68.6%, which signifies that the products have achieved the signature line of products. Additionally, SomnoDent Alpha has developed and received FDA approval in September 2016. The Alpha is an instant fit device used in sleep clinics for offering the patient and delivering efficacy data of a continuous open airway therapy (COAT) treatment relating to a specific patient before a device is custom-made for the patient.

Owing to the rising usage of oral devices across the globe and growing awareness of advanced oral devices for treating OSA will increase the demand for sleep apnea devices will ultimately increase the growth of the therapeutic obstructive sleep apnea devices market.

Report Segmentation and Scope:

The “Global Sleep Apnea Devices Market” is segmented based on diagnostic devices, therapeutic devices, end users, and geography. The sleep apnea diagnostic devices market is categorized into polysomnography devices, respiratory polygraphs, actigraphy systems, and oximeters. The market for sleep apnea is majorly driven by polysomnography devices, as these are more advanced and specialized devices than others.

The sleep apnea therapeutic devices market is segmented into facial interfaces, adaptive servo-ventilation instruments (ASV), positive airway pressure (PAP) devices, oxygen concentrators, airway clearance systems, oral appliances, and accessories.

The global sleep apnea market, based on the end-user, was segmented into home healthcare, sleep laboratories, and hospitals.

The sleep apnea devices market based on geography is segmented into North America (US, Canada, and Mexico), Europe (Germany, France, Italy, UK, Spain, and Rest of Europe), Asia Pacific (Australia, China, Japan, India, South Korea, and Rest of Asia Pacific), Middle East & Africa (South Africa, Saudi Arabia, UAE, and Rest of Middle East & Africa), and South & Central America (Brazil, Argentina, and Rest of South & Central America)

Segmental Analysis:

The global sleep apnea market, based on the end-user, was segmented into home healthcare, and sleep laboratories & hospitals. In 2017, the home healthcare segment held the largest share of the market by end user. In addition, the segment is also expected to grow at the fastest rate during the coming years owing to the advantages of the home healthcare segments. Home healthcare services are similar to skilled nursing facilities and hospitals available to treat patients at home. These facilities are used to treat injuries and diseases with more convenience and less cost. This service helps patients treat their sicknesses and injuries and helps them be self-sufficient to regain their independence. The patients feel more comfortable and relaxed in their own houses and respond well to the treatment.

Sleep Apnea Devices Market, by Procedure – 2017 and 2025

Regional Analysis: 

Based on geography, the sleep apnea devices market is divided into five key regions: North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa. In terms of revenue, North America dominated the sleep apnea devices market share. The North America sleep apnea devices market has been segmented into US, Canada, and Mexico. The US holds the largest share of the North American sleep apnea devices market. Increasing prevalence of sleep apnea disorder among the American population is key factor increasing the demand for sleep apnea devices, thus driving the  North America sleep apnea devices market.

Further, high prevalence of sleep apnea and rising awareness about sleep disorders and its risk factors in the US is likely to drive the US sleep apnea devices market. As per the Centers for Disease Control and Prevention (CDC), around one third of the US Population gets less than required amount of sleep. Additionally, as per the American Sleep Apnea Association, around 22 million Americans suffer from sleep apnea. Thus, the growing prevalence of sleep apnea will likely contribute to the growth of the US sleep apnea devices market size.

Additionally, the Asia Pacific sleep apnea devices market, based on countries, is segmented into China, Japan, Australia, India, South Korea, and the Rest of Asia Pacific. The sleep apnea devices market in Asia Pacific is likely to witness rapid growth owing to a large population, rising medical tourism and availability of cost-effective sleep apnea treatment devices. Thus, the abovementioned factors will likely drive the sleep apnea treatment devices market in the Asia Pacific region.

Further, Europe sleep apnea devices market includes the consolidated markets for France, Germany, the United Kingdom (UK), Spain, Italy, and the Rest of Europe. Europe occupies the second position in the global sleep apnea devices market and is expected to register a robust growth rate over the forecast period. The UK occupies a significant position in the Europe sleep apnea devices market and is expected to record vigorous growth during the forecast period. Various factors, such as focus on research and development activities on sleep disorders, increasing government support for research and favorable reimbursement policies in European countries such as U.K and Germany govern the growth of the market.

Middle East & Africa market includes countries such as Saudi Arabia, U.A.E., South Africa, Rest of the Middle East, and Africa. The region is expected to experience a steady growth rate from 2016 to 2025. The market for sleep apnea exhibits steady growth due to various factors such as the high prevalence of sleep disorders, the availability of qualified healthcare professionals and the focus on specialized sleep services, and the development of specialty hospitals.  In the Middle East, the high prevalence of obesity, smoking, and diabetes play an important role in the risk factors for OSA. Most OSA-related obesity is rapidly increasing in the Middle East (Saudi Arabia, United Arab Emirates, Qatar, Bahrain, Kuwait, and Oman). As per the recent study ‘Symptoms and Risk of Obstructive Sleep Apnea in Patients Attending Primary Health Care Clinics in Riyadh, Saudi Arabia’ published in January 2023, Saudi Arabian patients with hypertension were found to have an increased risk of developing sleep apnea.

The market in South and Central America is driven by various initiatives undertaken by government organizations and the need for treatment and diagnostic services in the region. The healthcare sector is observing steady but progressive growth in Brazil, increasing the demand for sleep apnea diagnostic and therapeutic devices in various healthcare settings.

Industry Developments and Future Opportunities:

Some of the activities undertaken by the company, which have promoted its growth are product launches, expansion, and others. Such activities the major market players is likely to boost the global sleep apnea diagnostic and therapeutic devices market. Various initiatives taken by key players operating in the global sleep apnea devices market are listed below:

  1. In August 2020, Nihon Kohden launched Polysmith 12 polysomnography software. Version 12 of the Polysmith software includes more than 40 market-driven features that offer sleep specialists improved workflow, analysis and outcomes.
  2. In October 2021, Evora Full – a compact full-face mask for sleep apnea has a floating seal and stability wings that work together to create the next generation of Dynamic Support Technology. The compact seal floats under the nose to provide patients with a clear line of sight, while stability wings keep the seal stable.
  3. In February 2020, Fisher & Paykel Healthcare Corporation Limited launched F&P Evora, a new nasal mask for the treatment of obstructive sleep apnea (OSA). The mask features CapFit headgear, which is designed to be put on like a baseball cap in one simple and intuitive movement.
  4. In August 2020, Cadwell Industries, Inc. re-introduced the ApneaTrak home sleep apnea testing (HSAT) device, with three models to meet multiple levels of clinical needs to help diagnose sleep apnea and to test the efficacy of treatments.

Covid-19 Impact:

The effect of the COVID-19 pandemic was largely seen in the sleep apnea devices industry. Most of the patients faced serious problems with PAP devices, and half of their daily activities were affected during the COVID-19  pandemic. The COVID-19 pandemic created serious problems in terms of public health and disrupted health services in many areas across the globe. The follow-up and treatment services for many patients with chronic diseases, as for OSAS, were interrupted during the lockdown period, which obligated the patients to handle their medical condition independently. In a study evaluating the impact of the COVID-19 pandemic in Europe, laboratory-based polysomnography was performed in 92.5% of the centers in the pre-pandemic period, it continued to be performed at only 20% of the centers during the pandemic, and even the rate of telemedicine-based sleep apnea diagnoses in these centers was reported to decrease from that 30% in the pre-pandemic period to 27.5% during the pandemic. Thus, this led to a negative impact on the sleep apnea devices market. However, CPAP was successful at raising oxygen levels among people who were hospitalized with COVID-19. CPAP was also used as a non-invasive treatment for respiratory failure in COVID-19 patients. Thus, the increase in the use of PAP devices reduced the negative impact of the pandemic on the sleep apnea devices market.

Nevertheless,  post-coronavirus vaccination programs, there was a quick recovery from the COVID-19 pandemic, likely favoring the sleep apnea devices market's growth.

Competitive Landscape and Key Companies:

Some of the prominent players operating in the global sleep apnea devices market include ResMed, Koninklijke Philips N.V., Fisher & Paykel, Braebon Medical Corporation, Compumedics Limited, BMC Medical Co., Ltd., Fisher & Paykel Healthcare Limited., SomnoMed Limited, Weinmann Emergency Medical Technology GmbH + CO. KG, Devilbiss Healthcare LLC among others. These companies focus on new product launches and geographical expansions to meet the growing consumer demand worldwide and increase their product range in specialty portfolios. They have a widespread global presence, allowing them to serve a large set of customers and subsequently increase their market share.

Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

Diagnostic Devices, Therapeutic Devices, and End User

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

This text is related
to country scope.

Frequently Asked Questions


What is the COVID 19 impact on the sleep apnea devices market?

As the COVID-19 pandemic progresses, the health care trade is predicted to face a drop in growth. The medical technologies and imaging phase is witnessing call in sales thanks to a smaller number of surgeries being meted out and delayed or prolonged instrumentation procurement.

What are sleep apnea?

A disorder which ends up into loud snoring. The primary reasons are throat muscle relaxing and once the brain stops sending signals to the respiratory muscles. The symptoms of sleep apnea are loud snoring, variations in respiration, awaking in between of sleep, lack of attention, way over daytime sleep, irritability and lack of sleep throughout night.

What is the key factor driving the sleep apnea devices market?

The growth of the worldwide sleep disorder devices market is attributed to the technological advancements, rising geriatric population and therefore the declining costs of sleep disorder devices are possible to own a positive impact on the expansion of the market within the returning years.

Which end-user held the largest share in the sleep apnea devices market?

In terms of user, the worldwide sleep disorder devices market is metameric into home health care, sleep laboratories and hospitals. The sleep laboratories and hospitals phase held the most important share of the market in 2017, and is additionally calculable to retain its dominance throughout the forecast amount.

The List of Companies - Sleep Apnea Devices Market

  1. RedMed
  2. Koninklijke Philips N.V.
  3. Fisher & Paykel
  4. Braebon Medical Corporation
  5. Compumedics Limited
  6. BMC Medical Co., Ltd.
  7. Fisher & Paykel Healthcare Limited.
  8. SomnoMed Limited
  9. Weinmann Emergency Medical Technology GmbH + CO. KG
  10. Devilbiss Healthcare LLC

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • 3.1 Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • 3.2 Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • 3.3 Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • 3.4 Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Trends and growth analysis reports related to Sleep Apnea Devices Market